MANN MICHAEL SCOTT (President) purchased 0.0% of their position (9K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $195.00 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+2K
Price / share
$0.02
Trade value
$45.40
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$21.20
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$21.00
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$22.20
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$21.90
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$21.90
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$20.80
% of position
Common Stock
Shares
+1K
Price / share
$0.02
Trade value
$20.60
% of position
Net shares
+9K
Net value
$195.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/14/2018 | P · Purchase | +2K | $0.02 | $45.40 | 0.0% | 26.36M | 26.36M |
| Common Stock Direct | 12/17/2018 | P · Purchase | +1K | $0.02 | $21.20 | 0.0% | 26.36M | 26.36M |
| Common Stock Direct | 12/17/2018 | P · Purchase | +1K | $0.02 | $21.00 | 0.0% | 26.36M | 26.36M |
| Common Stock Direct | 12/17/2018 | P · Purchase | +1K | $0.02 | $22.20 | 0.0% | 26.36M | 26.36M |
| Common Stock Direct | 12/19/2018 | P · Purchase | +1K | $0.02 | $21.90 | 0.0% | 26.36M | 26.36M |
| Common Stock Direct | 12/19/2018 | P · Purchase | +1K | $0.02 | $21.90 | 0.0% | 26.36M | 26.37M |
| Common Stock Direct | 12/20/2018 | P · Purchase | +1K | $0.02 | $20.80 | 0.0% | 26.37M | 26.37M |
| Common Stock Direct | 12/20/2018 | P · Purchase | +1K | $0.02 | $20.60 | 0.0% | 26.37M | 26.37M |
| Total | +9K | $195.00 | ||||||